Sands Capital Management, LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History
Sands Capital Management, LLC
- $27.6 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RARE
# of Institutions
335Shares Held
89.8MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$274 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$154 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$88.2 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$71.8 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.45MShares$67.1 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.92B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...